Glucocorticoid receptor

Implications for rheumatic diseases

Tomoshige Kino, E. Charmandari, G. P. Chrousos

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The glucocorticoid receptor (GR), a member of the nuclear receptor superfamily, mediates most of the known biologic effects of glucocorticoids. The human GR gene consists of 9 exons and expresses 2 alternative splicing isoforms, the GRa and GRβ. GRa is the classic receptor that binds to glucocorticoids and mediates most of the known actions of glucocorticoids, while GRβ does not bind to these hormones and exerts a dominant negative effect upon the GRα-induced transcriptional activity. Each of the two GR splice isoforms has 8 translational variants with specific transcriptional activity and tissue distribution. GRα consists of three subdomains, translocates from the cytoplasm into the nucleus upon binding to glucocorticoids, and regulates the transcriptional activity of numerous glucocorticoid-responsive genes either by binding to its cognate DNA sequences or by interacting with other transcription factors. In addition to these genomic actions, the GR also exerts rapid, non-genomic effects, which are possibly mediated by membranelocalised receptors or by translocation into the mitochondria. All these actions of the GR appear to play an important role in the regulation of the immune system. Specifically, the splicing variant GRβ may be involved in the pathogenesis of rheumatic diseases, while the circadian regulation of the GR activity via acetylation by the Clock transcription factor may have therapeutic implications for the preferential timing of glucocorticoid administration in autoimmune inflammatory disorders.

Original languageEnglish
JournalClinical and Experimental Rheumatology
Volume29
Issue number5 SUPPL. 68
Publication statusPublished - 2011
Externally publishedYes

Fingerprint

Glucocorticoid Receptors
Rheumatic Diseases
Glucocorticoids
Protein Isoforms
Transcription Factors
Alternative Splicing
Tissue Distribution
Acetylation
Cytoplasmic and Nuclear Receptors
Genes
Exons
Immune System
Mitochondria
Cytoplasm
Hormones

Keywords

  • Acetylation
  • Circadian rhythm
  • Glucocorticoid receptor
  • Non-genomic action
  • Splicing isoform
  • Transcriptional activity

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology

Cite this

Glucocorticoid receptor : Implications for rheumatic diseases. / Kino, Tomoshige; Charmandari, E.; Chrousos, G. P.

In: Clinical and Experimental Rheumatology, Vol. 29, No. 5 SUPPL. 68, 2011.

Research output: Contribution to journalArticle

Kino, Tomoshige ; Charmandari, E. ; Chrousos, G. P. / Glucocorticoid receptor : Implications for rheumatic diseases. In: Clinical and Experimental Rheumatology. 2011 ; Vol. 29, No. 5 SUPPL. 68.
@article{ee1b4ec704c543fc90027c57645049f1,
title = "Glucocorticoid receptor: Implications for rheumatic diseases",
abstract = "The glucocorticoid receptor (GR), a member of the nuclear receptor superfamily, mediates most of the known biologic effects of glucocorticoids. The human GR gene consists of 9 exons and expresses 2 alternative splicing isoforms, the GRa and GRβ. GRa is the classic receptor that binds to glucocorticoids and mediates most of the known actions of glucocorticoids, while GRβ does not bind to these hormones and exerts a dominant negative effect upon the GRα-induced transcriptional activity. Each of the two GR splice isoforms has 8 translational variants with specific transcriptional activity and tissue distribution. GRα consists of three subdomains, translocates from the cytoplasm into the nucleus upon binding to glucocorticoids, and regulates the transcriptional activity of numerous glucocorticoid-responsive genes either by binding to its cognate DNA sequences or by interacting with other transcription factors. In addition to these genomic actions, the GR also exerts rapid, non-genomic effects, which are possibly mediated by membranelocalised receptors or by translocation into the mitochondria. All these actions of the GR appear to play an important role in the regulation of the immune system. Specifically, the splicing variant GRβ may be involved in the pathogenesis of rheumatic diseases, while the circadian regulation of the GR activity via acetylation by the Clock transcription factor may have therapeutic implications for the preferential timing of glucocorticoid administration in autoimmune inflammatory disorders.",
keywords = "Acetylation, Circadian rhythm, Glucocorticoid receptor, Non-genomic action, Splicing isoform, Transcriptional activity",
author = "Tomoshige Kino and E. Charmandari and Chrousos, {G. P.}",
year = "2011",
language = "English",
volume = "29",
journal = "Clinical and Experimental Rheumatology",
issn = "0392-856X",
publisher = "Clinical and Experimental Rheumatology S.A.S.",
number = "5 SUPPL. 68",

}

TY - JOUR

T1 - Glucocorticoid receptor

T2 - Implications for rheumatic diseases

AU - Kino, Tomoshige

AU - Charmandari, E.

AU - Chrousos, G. P.

PY - 2011

Y1 - 2011

N2 - The glucocorticoid receptor (GR), a member of the nuclear receptor superfamily, mediates most of the known biologic effects of glucocorticoids. The human GR gene consists of 9 exons and expresses 2 alternative splicing isoforms, the GRa and GRβ. GRa is the classic receptor that binds to glucocorticoids and mediates most of the known actions of glucocorticoids, while GRβ does not bind to these hormones and exerts a dominant negative effect upon the GRα-induced transcriptional activity. Each of the two GR splice isoforms has 8 translational variants with specific transcriptional activity and tissue distribution. GRα consists of three subdomains, translocates from the cytoplasm into the nucleus upon binding to glucocorticoids, and regulates the transcriptional activity of numerous glucocorticoid-responsive genes either by binding to its cognate DNA sequences or by interacting with other transcription factors. In addition to these genomic actions, the GR also exerts rapid, non-genomic effects, which are possibly mediated by membranelocalised receptors or by translocation into the mitochondria. All these actions of the GR appear to play an important role in the regulation of the immune system. Specifically, the splicing variant GRβ may be involved in the pathogenesis of rheumatic diseases, while the circadian regulation of the GR activity via acetylation by the Clock transcription factor may have therapeutic implications for the preferential timing of glucocorticoid administration in autoimmune inflammatory disorders.

AB - The glucocorticoid receptor (GR), a member of the nuclear receptor superfamily, mediates most of the known biologic effects of glucocorticoids. The human GR gene consists of 9 exons and expresses 2 alternative splicing isoforms, the GRa and GRβ. GRa is the classic receptor that binds to glucocorticoids and mediates most of the known actions of glucocorticoids, while GRβ does not bind to these hormones and exerts a dominant negative effect upon the GRα-induced transcriptional activity. Each of the two GR splice isoforms has 8 translational variants with specific transcriptional activity and tissue distribution. GRα consists of three subdomains, translocates from the cytoplasm into the nucleus upon binding to glucocorticoids, and regulates the transcriptional activity of numerous glucocorticoid-responsive genes either by binding to its cognate DNA sequences or by interacting with other transcription factors. In addition to these genomic actions, the GR also exerts rapid, non-genomic effects, which are possibly mediated by membranelocalised receptors or by translocation into the mitochondria. All these actions of the GR appear to play an important role in the regulation of the immune system. Specifically, the splicing variant GRβ may be involved in the pathogenesis of rheumatic diseases, while the circadian regulation of the GR activity via acetylation by the Clock transcription factor may have therapeutic implications for the preferential timing of glucocorticoid administration in autoimmune inflammatory disorders.

KW - Acetylation

KW - Circadian rhythm

KW - Glucocorticoid receptor

KW - Non-genomic action

KW - Splicing isoform

KW - Transcriptional activity

UR - http://www.scopus.com/inward/record.url?scp=81155144643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81155144643&partnerID=8YFLogxK

M3 - Article

VL - 29

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

SN - 0392-856X

IS - 5 SUPPL. 68

ER -